Home Alzheimer’s Disease Pooled Prevalence, Risk Factors of Chemotherapy-Related VTE in Ovarian Cancer Are Revealed

Pooled Prevalence, Risk Factors of Chemotherapy-Related VTE in Ovarian Cancer Are Revealed

A study published in the World Journal of Surgical Oncology examining the prevalence, risk factors, and prognostic value of chemotherapy-associated venous thromboembolism (VTE) in patients with ovarian cancer found a pooled prevalence of 9% (95% CI, 0.06–0.12) for this group of patients.

The data also found substantial risk factors for chemotherapy-related VTE, potentially assisting future efforts to target preventative measures in patients with this disease.

“Our findings revealed that the pooled prevalence of chemotherapy-related VTE in OC was approximately 9% in [ovarian cancer] with substantial heterogeneity (88.9%),” wrote the investigators. “Considering that significant heterogeneity may impair the evidence quality of the pooled estimate, the meta-regressions based on publication time, sample size, and [Newcastle-Ottawa Scale] score were performed to explore the potential…

Continue Reading to the Source


Please enter your comment!
Please enter your name here

Most Popular

Patients Aged 70 or Older With Esophageal or EGJ Cancers Should Be Evaluated for Optimal Curative Therapy

Older patients with locoregional esophageal or esophagogastric junction (EGJ) cancer need to be evaluated for optimal curative therapy, including neoadjuvant chemoradiotherapy and surgical resection,...

Third COVID-19 Vaccine Earns Emergency Use Authorization Following Favorable Advisory Committee Meeting

The first single-dose COVID-19 vaccine was granted Emergency Use Authorization (EUA) by the FDA, according to its developer Janssen Pharmaceutical Companies of Johnson &...

Abiraterone Acetate, Apalutamide Likeliest to Improve Survival for Patients with Castration-Sensitive Prostate Cancer

In a comparison of systemic treatments as add-ons to androgen-deprivation therapy (ADT) for patients with metastatic castration-sensitive prostate cancer (mCSPC), abiraterone acetate (Zytiga) and...

Women of Minority Race/Ethnicity, Lower Socioeconomic Status Experience Lower Digital Breast Tomosynthesis Access

A cross-sectional study of digital breast tomosynthesis (DBT) screening published in JAMA Network Open indicated that women of minority race/ethnicity and lower socioeconomic status...

Recent Comments